To the extent a particular GLP-1 drug (for instance, tirzepatide or semaglutide) is removed from FDAs shortage list, and to the extent compounders and telehealth companies continue making and selling copies, they are subject to enforcement by FDA and, courts have held, civil liability to the drug company who owns the patent
At various points, theyve offered FDA-approved GLP-1 medications such as Wegovy through specific membership and pricing programs, but availability and pricing can shift based on eligibility, insurance coverage, and current offers
Nature 503 , 267271 (2013)
Conversely, patients with long-standing obesity, multiple previous weight loss attempts, or significant metabolic dysfunction may benefit from indefinite therapy
A simple log of injection sites and side effects helps you identify what works for your body